Aristo Pharma GmbH

Pharmaceutical Wholesale · Berlin

Aristo Pharma GmbH is a pharmaceutical wholesaler based in Berlin, Germany.

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Aristo Pharma GmbH Address & Contact

Address

Wallenroder Straße 8 - 10
13435 Berlin

Company profile

2002

Founded

Overview of Aristo Pharma GmbH

Aristo Pharma GmbH is a pharmaceutical company based in Berlin, engaged in both generic manufacturing and pharmaceutical wholesale. Founded in 2002 by a group of professionals with extensive experience in the pharmaceutical industry, the company has rapidly established itself as one of the leading generic manufacturers in Germany. The founders chose Berlin not only for its economic potential but also for its strategic location in Europe, facilitating access to markets and skilled labor. Aristo Pharma specializes in offering high-quality and cost-effective alternatives to original products, thereby making a significant contribution to the availability of medicines. The products are distributed directly to pharmacies and wholesalers in Germany and are also available in several European markets.

Services and Products

The product portfolio of Aristo Pharma GmbH is diverse and covers extensive therapeutic areas. Generics are particularly well represented for:

  • Cardiovascular diseases, including antihypertensive agents and cholesterol-lowering medications.
  • Respiratory diseases, including asthma and COPD medications.
  • Pain and inflammation therapies, including over-the-counter and prescription pain relievers.
  • Psychoactive medications for the treatment of depression and anxiety disorders.

Aristo Pharma develops and markets these generics, which are manufactured according to the strict quality standards of Good Manufacturing Practice (GMP). Compliance with these standards ensures consistent quality of the products and supports the company in its approval process by the Federal Institute for Drugs and Medical Devices (BfArM). Thus, Aristo Pharma meets all regulatory requirements of German and European pharmaceutical law. Furthermore, the company continually invests in research and development to bring innovative products to market and optimize existing formulations.

Location Berlin

As the federal capital and a hub for numerous industries, Berlin is an ideal location for Aristo Pharma GmbH. The city has established itself as a center for life sciences, providing a dynamic environment for the pharmaceutical industry. Proximity to key regulatory authorities such as BfArM and the European Medicines Agency (EMA) allows for close collaboration and accelerates the processing of approvals and other regulatory matters. In addition, companies benefit from the academic excellence of Berlin's universities and research institutions, which promote a variety of collaborations and partnerships in research and development.

Aristo Pharma GmbH actively contributes to regional economic development by not only creating jobs but also strengthening the healthcare sector in Berlin through its innovative power. The company's products are an important component of medication therapy in many German pharmacies, promoting accessibility and availability of medicines at affordable prices.

More information: Pharmaceutical wholesale in Berlin or all pharmaceutical wholesale in Germany on Sanoliste.

Frequently asked questions about Aristo Pharma GmbH

What is Aristo Pharma GmbH?

Aristo Pharma GmbH is a pharmaceutical wholesaler based in Berlin. The company supplies pharmacies, clinics and other healthcare facilities with medicines and pharmaceutical products.

What products does Aristo Pharma GmbH distribute?

As a pharmaceutical wholesaler, Aristo Pharma GmbH supplies pharmacies and healthcare facilities with prescription and over-the-counter medicines, medical devices and other pharmaceutical articles to GDP standards.

How can I contact Aristo Pharma GmbH?

You can reach Aristo Pharma GmbH using the contact details provided on this page. More information can be found on the company's website.

✓ Profile complete ☎ Phone 🌐 Website Logo

About Pharmaceutical Wholesale

Pharmaceutical wholesalers (Pharmagrosshandel) form the critical supply chain link between medicine manufacturers and authorised recipients such as pharmacies (Apotheken), hospitals (Krankenhäuser), medical practices and other licensed healthcare facilities. In Germany, the commercial distribution of medicinal products at wholesale level is a strictly regulated, licence-dependent activity. Every pharmaceutical wholesaler must hold a wholesale dealer authorisation (Großhandelserlaubnis) granted under Section 52a of the AMG (German Medicinal Products Act). This authorisation is issued by the pharmaceutical supervisory authority of the relevant German federal state and requires applicants to demonstrate suitable temperature-controlled storage premises, a documented quality management system, a qualified responsible person (verantwortliche Person), and ongoing compliance with the EU Good Distribution Practice (GDP) guidelines. Full-line wholesalers (Vollsortimenter) stock virtually the entire range of authorised medicines available in Germany, whereas specialist wholesalers focus on particular therapeutic areas or logistics requirements such as cold chain products, controlled substances (Betäubungsmittel) or imported parallel-trade medicines. Nationwide, around 15 full-line wholesalers and over 100 specialist wholesalers collectively ensure comprehensive medicine supply to more than 18,000 pharmacies across the country. This directory lists all authorised pharmaceutical wholesalers in Germany holding a valid authorisation under Section 52a AMG, with addresses and full contact details.

The Role of Pharmaceutical Wholesale in Germany's Medicine Supply

Germany's pharmaceutical wholesale sector is the backbone of the country's medicine distribution system, ensuring that more than 18,000 pharmacies and thousands of hospitals receive their medicine supplies reliably, often within hours of ordering. The German wholesale model is built around a hub-and-spoke logistics system: large national full-line wholesalers (Vollsortimenter) operate central and regional warehouses that stock virtually the entire range of authorised medicines. From these warehouses, medicines are delivered to pharmacies typically two or three times per day by refrigerated vans. This high delivery frequency means that pharmacies can operate with lean stock levels while still being able to fill patient prescriptions on the same day. Germany's medicine supply chain performed robustly during the COVID-19 pandemic, demonstrating the resilience of its wholesale infrastructure. The three largest full-line wholesalers in Germany collectively hold a dominant market share, but they compete with each other and with smaller regional and specialist wholesalers.

Legal Requirements Under Section 52a AMG and EU GDP

Operating as a pharmaceutical wholesaler in Germany requires a wholesale dealer authorisation (Großhandelserlaubnis) granted by the competent pharmaceutical supervisory authority of the relevant German federal state under Section 52a of the AMG. This authorisation is not automatic and requires applicants to demonstrate compliance with a detailed set of prerequisites before trading can begin. The premises must be suitable for temperature-controlled storage, with validated temperature mapping studies for all storage areas. A documented quality management system (QMS) must be in place covering procurement, storage, pick and dispatch, complaints, returns, recalls, counterfeiting detection and self-inspections. A qualified responsible person (verantwortliche Person) with the relevant pharmaceutical or scientific qualifications must be designated and approved by the authority. After authorisation is granted, companies must comply with the EU GDP guidelines (EudraLex Volume 5), which are periodically updated. Inspections by the state pharmaceutical authority verify ongoing compliance.

Specialist Wholesale and Cold Chain Logistics in Germany

Beyond full-line wholesale, Germany has a developed specialist wholesale sector catering to specific product categories that require particular expertise or infrastructure. Cold chain wholesale is especially important for biological medicines including monoclonal antibodies, vaccines, insulin and plasma-derived products, which must be stored and transported within defined temperature ranges (typically 2 to 8 degrees Celsius). Controlled substance (Betäubungsmittel) wholesale requires additional authorisation under the Betäubungsmittelgesetz (BtMG) and is subject to strict record-keeping and security requirements. Import wholesale specialises in parallel-imported medicines, sourcing products authorised in other EU member states at lower prices and relabelling them in accordance with German regulatory requirements. Specialty pharmacy wholesale focuses on high-value oncology drugs, immunosuppressants and rare disease treatments. Each of these specialist segments requires specific expertise, infrastructure and additional regulatory permissions beyond the standard Section 52a AMG authorisation.

Medicinal Product Supply Chain Security and Falsification Protection

The integrity of the pharmaceutical supply chain is a central responsibility of pharmaceutical wholesale. Since February 2019, the EU Falsified Medicines Directive (FMD) has been fully in force: every prescription medicinal product pack carries an individual 2D data matrix code, which is scanned and verified at the wholesaler and end recipient in the national verification database (in Germany: securPharm). Temperature-critical products, including biologics, insulins and vaccines, require an unbroken cold chain (2–8 °C or frozen), which the wholesaler ensures with validated cold stores, temperature-controlled transport and temperature monitoring. Controlled substances are additionally subject to the Narcotics Act (BtMG) with strict documentation requirements. Recall management and batch traceability in accordance with GDP guidelines are mandatory. Sanoliste identifies specialist wholesalers for cold chain, controlled substances and parallel import medicines separately.

What does a pharmaceutical wholesaler do?

Pharmaceutical wholesalers procure, store and distribute medicines to pharmacies, hospitals and other authorised recipients. In Germany, wholesale trade in medicines requires authorisation under Section 52a AMG.

What authorisation does a pharmaceutical wholesaler need?

A pharmaceutical wholesaler must hold authorisation under Section 52a of the AMG (German Medicinal Products Act). Requirements include suitable premises, a qualified responsible person and compliance with EU Good Distribution Practice (GDP) guidelines.

How do I find an authorised pharmaceutical wholesaler in Germany?

Authorised pharmaceutical wholesalers are registered with the competent state authority under Section 52a AMG. Sanoliste lists all wholesalers with valid authorisation, including specialisations in cold chain logistics, controlled substances or imported medicines. Filter by federal state for a regional search.

How many pharmaceutical wholesalers are there in Germany?

Germany has approximately 15 full-line pharmaceutical wholesalers (Vollsortimenter) that stock the full range of authorised medicines and deliver to pharmacies nationwide, alongside more than 100 specialist wholesalers focusing on specific therapeutic areas, temperature-sensitive biologics or controlled substances. Together they supply over 18,000 pharmacies across the country.

What does EU Good Distribution Practice (GDP) require?

The EU GDP guidelines (2013/C 343/01) set out requirements for the proper distribution of medicinal products. For pharmaceutical wholesalers this includes maintaining appropriate temperature-controlled storage conditions (especially for cold-chain products), operating a documented quality management system, training qualified personnel, conducting supplier and customer qualification audits, maintaining full traceability records, and having procedures for handling suspected counterfeits, complaints and recalls.

Can a pharmaceutical wholesaler in Germany supply directly to patients?

No. In Germany, pharmaceutical wholesalers are not permitted to supply medicines directly to patients. They may only supply authorised recipients such as pharmacies, hospitals, medical practices (under specific conditions) and other licensed wholesalers. Patients must obtain prescription medicines through a pharmacy, which in turn sources its stock from authorised wholesalers or directly from manufacturers.

What is the difference between a pharmaceutical wholesaler and a medicine broker?

A pharmaceutical wholesaler physically holds medicines in stock, stores them and delivers to authorised recipients such as pharmacies and hospitals. They require a wholesale authorisation under § 52a AMG and must maintain GDP-compliant storage conditions. A medicine broker, by contrast, does not take possession of medicines but merely arranges transactions between manufacturers, wholesalers and buyers. Brokering activities are subject to registration under § 52b AMG.

Last updated: 17.04.2026 · Category: Pharmaceutical Wholesale